Reading, MA, United States of America

Jeffrey P Ciavarri



 

Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: Inventor Profile: Jeffrey P. Ciavarri

Introduction

Jeffrey P. Ciavarri is an accomplished inventor based in Reading, Massachusetts, USA. With a remarkable portfolio of 13 patents, he has significantly contributed to the field of pharmaceutical developments, particularly in the area of compound formulations that address various medical conditions.

Latest Patents

Among his latest innovations are notable patents concerning heteroaryls and their therapeutic uses. One patent outlines a compound formula that comprises pharmaceutically acceptable salts, specifically designed as inhibitors of VPS34. This groundbreaking work holds promise for treating proliferative, inflammatory, and cardiovascular disorders, showcasing the relevance of his inventions in contemporary medical treatments.

Career Highlights

Over the years, Jeffrey has built his career by working with reputable organizations such as Millennium Pharmaceuticals Limited and the University of Pennsylvania. His experience in these institutions has enriched his knowledge and expertise, allowing him to innovate effectively within the pharmaceutical landscape.

Collaborations

Throughout his career, Jeffrey has worked alongside esteemed colleagues, including Paul E. Fleming and Indu T. Bharathan. These collaborations have been pivotal in enhancing his research efforts and expanding the impact of his innovations in the field.

Conclusion

Jeffrey P. Ciavarri stands out as a dynamic inventor whose contributions to pharmaceutical research are noteworthy. With a strong background and a commitment to addressing significant health challenges through his patented inventions, he continues to leave a substantial mark in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…